PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES Trademark 77741348

Trademark: 77741348

Word

PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES

Status

Dead

Status Code

602

Status Date

Wednesday, March 17, 2010

Serial Number

77741348

Mark Type

4000

Filing Date

Wednesday, May 20, 2009

Abandoned Date

Friday, February 19, 2010

Trademark Owner History

Classifications

42 Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

PIONEERS: PHASE THREE TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES

Trademark Events

Mar 17, 2010

Abandonment Notice Mailed - Failure To Respond

Mar 17, 2010

Abandonment - Failure To Respond Or Late Response

Aug 18, 2009

Non-Final Action Mailed

Aug 18, 2009

Non-Final Action Written

Aug 10, 2009

Assigned To Examiner

May 27, 2009

Notice Of Pseudo Mark Mailed

May 26, 2009

New Application Office Supplied Data Entered In Tram

May 23, 2009

New Application Entered In Tram

NEED2BE

Trademark Alertz updated from USPTO on 2030-01-24